â€œThey are the very first individuals to have ever receive this agent,â€ Dr. Bruce Ribner, director of Emoryâ€™s Infectious Disease Unit, told a news conference. â€œThere is no prior experience with it, and frankly, we do not know whether it helped them, whether it made no difference, or even, theoretically, if it delayed their recovery.â€